The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome
Abstract
Punding is a term that was coined originally to describe complex prolonged, purposeless, and stereotyped behaviour in chronic amphetamine users. A structured interview of 50 patients with higher dopamine replacement therapy requirements (>800 levodopa equivalent units/day) from 123 unselected patients with Parkinson's disease (PD) from a PD clinic identified 17 (14%) patients with punding. Punding was acknowledged as disruptive and unproductive by the patients themselves, but forcible attempts by family to interrupt the behaviour led to irritability and dysphoria. Punding was associated with very high doses of dopamine replacement therapy often related to a pattern of chronic inappropriate overuse of dopaminergic medication. We believe that this is an underreported, socially disabling phenomenon that is commonly associated with the syndrome of dopamine dysregulation and is phenomenologically distinct from both obsessive‐compulsive disorder and mania. © 2004 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Self-citationJentsch, J. D., & Taylor, J. R. (1999) · Psychopharmacology · doi:10.1007/pl00005483 · Cited by 1,545
Ikemoto, S., & Panksepp, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00023-5 · Cited by 1,450
Toward a neurobiology of obsessive-compulsive disorder
Graybiel, A. M., & Rauch, S. L. (2000) · Neuron · doi:10.1016/s0896-6273(00)00113-6 · Cited by 864
The validation of a new obsessive–compulsive disorder scale: The Obsessive–Compulsive Inventory
Foa, E. B., Kozak, M. J., Salkovskis, P. M., Coles, M. E., & Amir, N. (1998) · Psychological Assessment · doi:10.1037/1040-3590.10.3.206 · Cited by 719 · cited 1×
“Nonpunders took L-dopa (33 patients), entacapone (14), pergolide (10), amantadine (7), ropinirole (6), apomorphine (4), cabergoline (3), pramipexole (2), bromocriptine (2) and selegiline (1).”
BackgroundGiovannoni, G. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.4.423 · Cited by 587
LAPLANE, D., LEVASSEUR, M., PILLON, B., DUBOIS, B., BAULAC, M., MAZOYER, B., DINH, S. T., SETTE, G., DANZE, F., & BARON, J. C. (1989) · Brain · doi:10.1093/brain/112.3.699 · Cited by 415
Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?
Lawrence, A. D., Evans, A. H., & Lees, A. J. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00529-5 · Cited by 282
Self-citationSahakian, B. J., Robbins, T. W., Morgan, M. J., & Iversen, S. D. (1975) · Brain Research · doi:10.1016/0006-8993(75)90975-0 · Cited by 278
Lensi, P., Cassano, G. B., Correddu, G., Ravagli, S., Kunovac, J. L., & Akiskal, H. S. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.1.101 · Cited by 262
Cited by
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010) · Movement Disorders · doi:10.1002/mds.23429 · Cited by 4,219
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Parkinson's disease symptoms: The patient's perspective
Politis, M., Wu, K., Molloy, S., G. Bain, P., Chaudhuri, K. R., & Piccini, P. (2010) · Movement Disorders · doi:10.1002/mds.23135 · Cited by 647
Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease
Weintraub, D., Hoops, S., Shea, J. A., Lyons, K. E., Pahwa, R., Driver‐Dunckley, E. D., Adler, C. H., Potenza, M. N., Miyasaki, J., Siderowf, A. D., et al. (2009) · Movement Disorders · doi:10.1002/mds.22571 · Cited by 528
Gallagher, D. A., Lees, A. J., & Schrag, A. (2010) · Movement Disorders · doi:10.1002/mds.23394 · Cited by 509
Self-citationSteeves, T. D. L., Miyasaki, J., Zurowski, M., Lang, A. E., Pellecchia, G., Van Eimeren, T., Rusjan, P., Houle, S., & Strafella, A. P. (2009) · Brain · doi:10.1093/brain/awp054 · Cited by 502
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
Evans, A. H., Pavese, N., Lawrence, A. D., Tai, Y. F., Appel, S., Doder, M., Brooks, D. J., Lees, A. J., & Piccini, P. (2006) · Annals of Neurology · doi:10.1002/ana.20822 · Cited by 473
Self-citationAn update on the diagnosis and treatment of Parkinson disease
Rizek, P., Kumar, N., & Jog, M. S. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.151179 · Cited by 447
Parkinson's disease: The quintessential neuropsychiatric disorder
Weintraub, D., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23664 · Cited by 423
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease
Voon, V., Hassan, K., Zurowski, M., de Souza, M., Thomsen, T., Fox, S., Lang, A. E., & Miyasaki, J. (2006) · Neurology · doi:10.1212/01.wnl.0000238503.20816.13 · Cited by 418
Questionnaire for impulsive‐compulsive disorders in Parkinson's Disease–Rating Scale
Weintraub, D., Mamikonyan, E., Papay, K., Shea, J. A., Xie, S. X., & Siderowf, A. (2012) · Movement Disorders · doi:10.1002/mds.24023 · Cited by 391
Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
Voon, V., Napier, T. C., Frank, M. J., Sgambato-Faure, V., Grace, A. A., Rodriguez-Oroz, M., Obeso, J., Bezard, E., & Fernagut, P.-O. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30004-2 · Cited by 359
Current approaches to the treatment of Parkinson’s disease
Jankovic, J. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2006 · Cited by 342
Voon, V., Fernagut, P.-O., Wickens, J., Baunez, C., Rodriguez, M., Pavon, N., Juncos, J. L., Obeso, J. A., & Bezard, E. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70287-x · Cited by 335
Clinical spectrum of impulse control disorders in Parkinson’s disease
Weintraub, D., David, A. S., Evans, A. H., Grant, J. E., & Stacy, M. (2015) · Movement Disorders · doi:10.1002/mds.26016 · Cited by 311
Self-citationWilliams, D. R., & Lees, A. J. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70146-0 · Cited by 300
Self-citationO'Sullivan, S. S., Wu, K., Politis, M., Lawrence, A. D., Evans, A. H., Bose, S. K., Djamshidian, A., Lees, A. J., & Piccini, P. (2011) · Brain · doi:10.1093/brain/awr003 · Cited by 297
Self-citationSubthalamic stimulation in Parkinson’s disease: restoring the balance of motivated behaviours
Lhommée, E., Klinger, H., Thobois, S., Schmitt, E., Ardouin, C., Bichon, A., Kistner, A., Fraix, V., Xie, J., Aya Kombo, M., et al. (2012) · Brain · doi:10.1093/brain/aws078 · Cited by 296
Anxiety rating scales in Parkinson's disease: Critique and recommendations
Leentjens, A. F. G., Dujardin, K., Marsh, L., Martinez‐Martin, P., Richard, I. H., Starkstein, S. E., Weintraub, D., Sampaio, C., Poewe, W., Rascol, O., et al. (2008) · Movement Disorders · doi:10.1002/mds.22233 · Cited by 275
Impulse Control and Related Disorders in Parkinson's Disease
Weintraub, D., & Claassen, D. O. (2017) · International Review of Neurobiology · doi:10.1016/bs.irn.2017.04.006 · Cited by 272
Dopamine Dysregulation Syndrome: An Overview of its Epidemiology, Mechanisms and Management
OʼSullivan, S. S., Evans, A. H., & Lees, A. J. (2009) · CNS Drugs · doi:10.2165/00023210-200923020-00005 · Cited by 265
Self-citationThe neurobiology of repetitive behavior: …and men
Langen, M., Durston, S., Kas, M. J. H., van Engeland, H., & Staal, W. G. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.005 · Cited by 263
Compulsive eating and weight gain related to dopamine agonist use
Nirenberg, M. J., & Waters, C. (2006) · Movement Disorders · doi:10.1002/mds.20757 · Cited by 262
Dopamine dysregulation syndrome in Parkinson's disease
Evans, A. H., & Lees, A. J. (2004) · Current Opinion in Neurology · doi:10.1097/01.wco.0000137528.23126.41 · Cited by 257
Self-citationTrial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers
Okai, D., Askey-Jones, S., Samuel, M., O’Sullivan, S. S., Chaudhuri, K. R., Martin, A., Mack, J., Brown, R. G., & David, A. S. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840678 · Cited by 202
Frontal-striatal abnormalities underlying behaviours in the compulsive-impulsive spectrum
den Heuvel, O. A. V., der Werf, Y. D. V., Verhoef, K. M. W., de Wit, S., Berendse, H. W., Wolters, E. C., Veltman, D. J., & Groenewegen, H. J. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.043 · Cited by 105
Impulse control disorders in Parkinson's disease
Vilas, D., Pont-Sunyer, C., & Tolosa, E. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70026-8 · Cited by 77
Nakum, S., & Cavanna, A. E. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.02.017 · Cited by 70
Wu, K., Politis, M., & Piccini, P. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.075820 · Cited by 55
Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward
Evans, A. H., Lawrence, A. D., Cresswell, S. A., Katzenschlager, R., & Lees, A. J. (2010) · Movement Disorders · doi:10.1002/mds.22898 · Cited by 51
Self-citationParaphilias and paraphilic disorders in Parkinson's disease: a systematic review of the literature
Solla, P., Bortolato, M., Cannas, A., Mulas, C. S., & Marrosu, F. (2015) · Movement Disorders · doi:10.1002/mds.26157 · Cited by 46
Ceravolo, R., Frosini, D., Rossi, C., & Bonuccelli, U. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5715-0 · Cited by 41
Modeling dopamine dysfunction in autism spectrum disorder: from invertebrates to vertebrates
DiCarlo, G. E., & Wallace, M. T. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.017 · Cited by 39
Impulse Control Disorders in Parkinson’s Disease: A Psychosocial Perspective
Delaney, M., Leroi, I., Simpson, J., & Overton, P. G. (2012) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-012-9302-7 · Cited by 26
Management of impulse control disorders in Parkinson's disease
Zhang, S., Dissanayaka, N. N., Dawson, A., O'Sullivan, J. D., Mosley, P., Hall, W., & Carter, A. (2016) · International Psychogeriatrics · doi:10.1017/s104161021600096x · Cited by 22
Self-citation
Metadata
- Authors
- Evans, A. H., Katzenschlager, R., Paviour, D., O'Sullivan, J. D., Appel, S., Lawrence, A. D., & Lees, A. J.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2004-02-10
- Volume
- 19
- Issue
- 4
- Pages
- 397-405
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2012886729
- Cited by
- 474
- References
- 39
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.